Cargando…
Imaging of Escherichia coli K5 and glycosaminoglycan precursors via targeted metabolic labeling of capsular polysaccharides in bacteria
The introduction of unnatural chemical moieties into glycosaminoglycans (GAGs) has enormous potential to facilitate studies of the mechanism and application of these critical, widespread molecules. Unnatural N-acetylhexosamine analogs were metabolically incorporated into the capsule polysaccharides...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937569/ https://www.ncbi.nlm.nih.gov/pubmed/36800421 http://dx.doi.org/10.1126/sciadv.ade4770 |
_version_ | 1784890451155746816 |
---|---|
author | Wang, Yu-Jia Li, Lian Yu, Jie Hu, Hong-Yu Liu, Zi-Xu Jiang, Wen-Jie Xu, Wei Guo, Xue-Ping Wang, Feng-Shan Sheng, Ju-Zheng |
author_facet | Wang, Yu-Jia Li, Lian Yu, Jie Hu, Hong-Yu Liu, Zi-Xu Jiang, Wen-Jie Xu, Wei Guo, Xue-Ping Wang, Feng-Shan Sheng, Ju-Zheng |
author_sort | Wang, Yu-Jia |
collection | PubMed |
description | The introduction of unnatural chemical moieties into glycosaminoglycans (GAGs) has enormous potential to facilitate studies of the mechanism and application of these critical, widespread molecules. Unnatural N-acetylhexosamine analogs were metabolically incorporated into the capsule polysaccharides of Escherichia coli and Bacillus subtilis via bacterial metabolism. Targeted metabolic labeled hyaluronan and the precursors of heparin and chondroitin sulfate were obtained. The azido-labeled polysaccharides (purified or in capsules) were reacted with dyes, via bioorthogonal chemistry, to enable detection and imaging. Site-specific introduction of fluorophores directly onto cell surfaces affords another choice for observing and quantifying bacteria in vivo and in vitro. Furthermore, azido-polysaccharides retain similar biological properties to their natural analogs, and reliable and predictable introduction of functionalities, such as fluorophores, onto azido-N-hexosamines in the disaccharide repeat units provides chemical tools for imaging and metabolic analysis of GAGs in vivo and in vitro. |
format | Online Article Text |
id | pubmed-9937569 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Association for the Advancement of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-99375692023-02-18 Imaging of Escherichia coli K5 and glycosaminoglycan precursors via targeted metabolic labeling of capsular polysaccharides in bacteria Wang, Yu-Jia Li, Lian Yu, Jie Hu, Hong-Yu Liu, Zi-Xu Jiang, Wen-Jie Xu, Wei Guo, Xue-Ping Wang, Feng-Shan Sheng, Ju-Zheng Sci Adv Biomedicine and Life Sciences The introduction of unnatural chemical moieties into glycosaminoglycans (GAGs) has enormous potential to facilitate studies of the mechanism and application of these critical, widespread molecules. Unnatural N-acetylhexosamine analogs were metabolically incorporated into the capsule polysaccharides of Escherichia coli and Bacillus subtilis via bacterial metabolism. Targeted metabolic labeled hyaluronan and the precursors of heparin and chondroitin sulfate were obtained. The azido-labeled polysaccharides (purified or in capsules) were reacted with dyes, via bioorthogonal chemistry, to enable detection and imaging. Site-specific introduction of fluorophores directly onto cell surfaces affords another choice for observing and quantifying bacteria in vivo and in vitro. Furthermore, azido-polysaccharides retain similar biological properties to their natural analogs, and reliable and predictable introduction of functionalities, such as fluorophores, onto azido-N-hexosamines in the disaccharide repeat units provides chemical tools for imaging and metabolic analysis of GAGs in vivo and in vitro. American Association for the Advancement of Science 2023-02-17 /pmc/articles/PMC9937569/ /pubmed/36800421 http://dx.doi.org/10.1126/sciadv.ade4770 Text en Copyright © 2023 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (https://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited. |
spellingShingle | Biomedicine and Life Sciences Wang, Yu-Jia Li, Lian Yu, Jie Hu, Hong-Yu Liu, Zi-Xu Jiang, Wen-Jie Xu, Wei Guo, Xue-Ping Wang, Feng-Shan Sheng, Ju-Zheng Imaging of Escherichia coli K5 and glycosaminoglycan precursors via targeted metabolic labeling of capsular polysaccharides in bacteria |
title | Imaging of Escherichia coli K5 and glycosaminoglycan precursors via targeted metabolic labeling of capsular polysaccharides in bacteria |
title_full | Imaging of Escherichia coli K5 and glycosaminoglycan precursors via targeted metabolic labeling of capsular polysaccharides in bacteria |
title_fullStr | Imaging of Escherichia coli K5 and glycosaminoglycan precursors via targeted metabolic labeling of capsular polysaccharides in bacteria |
title_full_unstemmed | Imaging of Escherichia coli K5 and glycosaminoglycan precursors via targeted metabolic labeling of capsular polysaccharides in bacteria |
title_short | Imaging of Escherichia coli K5 and glycosaminoglycan precursors via targeted metabolic labeling of capsular polysaccharides in bacteria |
title_sort | imaging of escherichia coli k5 and glycosaminoglycan precursors via targeted metabolic labeling of capsular polysaccharides in bacteria |
topic | Biomedicine and Life Sciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937569/ https://www.ncbi.nlm.nih.gov/pubmed/36800421 http://dx.doi.org/10.1126/sciadv.ade4770 |
work_keys_str_mv | AT wangyujia imagingofescherichiacolik5andglycosaminoglycanprecursorsviatargetedmetaboliclabelingofcapsularpolysaccharidesinbacteria AT lilian imagingofescherichiacolik5andglycosaminoglycanprecursorsviatargetedmetaboliclabelingofcapsularpolysaccharidesinbacteria AT yujie imagingofescherichiacolik5andglycosaminoglycanprecursorsviatargetedmetaboliclabelingofcapsularpolysaccharidesinbacteria AT huhongyu imagingofescherichiacolik5andglycosaminoglycanprecursorsviatargetedmetaboliclabelingofcapsularpolysaccharidesinbacteria AT liuzixu imagingofescherichiacolik5andglycosaminoglycanprecursorsviatargetedmetaboliclabelingofcapsularpolysaccharidesinbacteria AT jiangwenjie imagingofescherichiacolik5andglycosaminoglycanprecursorsviatargetedmetaboliclabelingofcapsularpolysaccharidesinbacteria AT xuwei imagingofescherichiacolik5andglycosaminoglycanprecursorsviatargetedmetaboliclabelingofcapsularpolysaccharidesinbacteria AT guoxueping imagingofescherichiacolik5andglycosaminoglycanprecursorsviatargetedmetaboliclabelingofcapsularpolysaccharidesinbacteria AT wangfengshan imagingofescherichiacolik5andglycosaminoglycanprecursorsviatargetedmetaboliclabelingofcapsularpolysaccharidesinbacteria AT shengjuzheng imagingofescherichiacolik5andglycosaminoglycanprecursorsviatargetedmetaboliclabelingofcapsularpolysaccharidesinbacteria |